| Literature DB >> 23261598 |
Sara Christina Stolze1, Edgar Deu, Farnusch Kaschani, Nan Li, Bogdan I Florea, Kerstin H Richau, Tom Colby, Renier A L van der Hoorn, Hermen S Overkleeft, Matthew Bogyo, Markus Kaiser.
Abstract
The marine natural product symplostatin 4 (Sym4) has been recognized as a potent antimalarial agent. However, its mode of action and, in particular, direct targets have to date remained elusive. We report a chemical synthesis of Sym4 and show that Sym4-treatment of P. falciparum-infected red blood cells (RBCs) results in the generation of a swollen food vacuole phenotype and a reduction of parasitemia at nanomolar concentrations. We furthermore demonstrate that Sym4 is a nanomolar inhibitor of the P. falciparum falcipains in infected RBCs, suggesting inhibition of the hemoglobin degradation pathway as Sym4's mode of action. Finally, we reveal a critical influence of the unusual methyl-methoxypyrrolinone (mmp) group of Sym4 for potent inhibition, indicating that Sym4 derivatives with such a mmp moiety might represent viable lead structures for the development of antimalarial falcipain inhibitors.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23261598 PMCID: PMC3601557 DOI: 10.1016/j.chembiol.2012.09.020
Source DB: PubMed Journal: Chem Biol ISSN: 1074-5521